Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model.
Saved in:
| Title: | Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model. |
|---|---|
| Authors: | Stringer, Megan1, Abeysekera, Irushi2, Dria, Karl J.3, Roper, Randall J.2 rjroper@iupui.edu, Goodlett, Charles R.1 |
| Source: | Pharmacology, Biochemistry & Behavior. Nov2015, Vol. 138, p70-79. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!